A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer

There is an unmet clinical need to identify patients with early-stage non-small cell lung cancer (NSCLC) who are likely to develop recurrence and to predict their therapeutic responses. Our previous study developed a qRT-PCR-based seven-gene microfluidic assay to predict the recurrence risk and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qing, Falatovich, Brianne, Singh, Salvi, Ivanov, Alexey V., Eubank, Timothy D., Guo, Nancy Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745553/
https://www.ncbi.nlm.nih.gov/pubmed/35008645
http://dx.doi.org/10.3390/ijms23010219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745553/
https://www.ncbi.nlm.nih.gov/pubmed/35008645
http://dx.doi.org/10.3390/ijms23010219

Ejemplares similares